nodes	percent_of_prediction	percent_of_DWPC	metapath
Nepafenac—PTGS1—chronic kidney failure	0.604	0.636	CbGaD
Nepafenac—PTGS2—chronic kidney failure	0.345	0.364	CbGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—chronic kidney failure	0.0016	0.0457	CbGpPWpGaD
Nepafenac—PTGS2—Calcium signaling in the CD4+ TCR pathway—CABIN1—chronic kidney failure	0.00119	0.0339	CbGpPWpGaD
Nepafenac—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS1—chronic kidney failure	0.00117	0.0334	CbGpPWpGaD
Nepafenac—PTGS2—nephron—chronic kidney failure	0.00108	0.199	CbGeAlD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NOS1—chronic kidney failure	0.00092	0.0262	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—PTGS1—chronic kidney failure	0.000917	0.0262	CbGpPWpGaD
Nepafenac—PTGS2—Eicosanoid Synthesis—PTGS1—chronic kidney failure	0.000761	0.0217	CbGpPWpGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—CRP—chronic kidney failure	0.00066	0.0188	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—PTGS1—chronic kidney failure	0.000637	0.0181	CbGpPWpGaD
Nepafenac—PTGS1—artery—chronic kidney failure	0.000629	0.116	CbGeAlD
Nepafenac—PTGS2—artery—chronic kidney failure	0.000601	0.111	CbGeAlD
Nepafenac—PTGS1—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.000583	0.0166	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2B6—chronic kidney failure	0.000568	0.0162	CbGpPWpGaD
Nepafenac—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—chronic kidney failure	0.000565	0.0161	CbGpPWpGaD
Nepafenac—Ketorolac—PTGS1—chronic kidney failure	0.000558	0.054	CrCbGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—EDN1—chronic kidney failure	0.000551	0.0157	CbGpPWpGaD
Nepafenac—Bromfenac—PTGS1—chronic kidney failure	0.000535	0.0518	CrCbGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—CRP—chronic kidney failure	0.000524	0.0149	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOX4—chronic kidney failure	0.00051	0.0145	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2C18—chronic kidney failure	0.000493	0.014	CbGpPWpGaD
Nepafenac—PTGS1—blood plasma—chronic kidney failure	0.000472	0.0872	CbGeAlD
Nepafenac—PTGS2—Arachidonic acid metabolism—CYP2C19—chronic kidney failure	0.000462	0.0132	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS1—chronic kidney failure	0.000455	0.0441	CrCbGaD
Nepafenac—PTGS2—blood plasma—chronic kidney failure	0.000451	0.0834	CbGeAlD
Nepafenac—PTGS1—Overview of nanoparticle effects—PTGS2—chronic kidney failure	0.000443	0.0126	CbGpPWpGaD
Nepafenac—PTGS2—Prostaglandin Synthesis and Regulation—EDN1—chronic kidney failure	0.000438	0.0125	CbGpPWpGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—PTGS1—chronic kidney failure	0.000423	0.0121	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS1—chronic kidney failure	0.000423	0.041	CrCbGaD
Nepafenac—Fenbufen—PTGS1—chronic kidney failure	0.000414	0.0401	CrCbGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP2C19—chronic kidney failure	0.000408	0.0116	CbGpPWpGaD
Nepafenac—Diclofenac—CYP2C18—chronic kidney failure	0.000405	0.0393	CrCbGaD
Nepafenac—Mebendazole—CYP1A1—chronic kidney failure	0.000371	0.0359	CrCbGaD
Nepafenac—PTGS1—Eicosanoid Synthesis—PTGS2—chronic kidney failure	0.000367	0.0105	CbGpPWpGaD
Nepafenac—Salsalate—PTGS1—chronic kidney failure	0.000359	0.0348	CrCbGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—chronic kidney failure	0.00035	0.00998	CbGpPWpGaD
Nepafenac—PTGS1—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.000343	0.00979	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SCARB1—chronic kidney failure	0.000342	0.00976	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP3A4—chronic kidney failure	0.000323	0.00921	CbGpPWpGaD
Nepafenac—Ketorolac—PTGS2—chronic kidney failure	0.000319	0.0309	CrCbGaD
Nepafenac—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—chronic kidney failure	0.000318	0.00906	CbGpPWpGaD
Nepafenac—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—chronic kidney failure	0.000307	0.00876	CbGpPWpGaD
Nepafenac—Bromfenac—PTGS2—chronic kidney failure	0.000306	0.0296	CrCbGaD
Nepafenac—PTGS1—Biological oxidations—CYP2B6—chronic kidney failure	0.000302	0.0086	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—LPL—chronic kidney failure	0.000302	0.0086	CbGpPWpGaD
Nepafenac—Diclofenac—CYP2B6—chronic kidney failure	0.000301	0.0291	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—TNF—chronic kidney failure	0.000299	0.00852	CbGpPWpGaD
Nepafenac—Fenoprofen—PTGS1—chronic kidney failure	0.000297	0.0288	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—CYP1A1—chronic kidney failure	0.000291	0.00831	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ABCA1—chronic kidney failure	0.000288	0.00822	CbGpPWpGaD
Nepafenac—Modafinil—CYP2B6—chronic kidney failure	0.000283	0.0274	CrCbGaD
Nepafenac—PTGS2—S1P1 pathway—VEGFA—chronic kidney failure	0.000277	0.00789	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS1—chronic kidney failure	0.000275	0.0267	CrCbGaD
Nepafenac—PTGS2—Arachidonic acid metabolism—CYP1A1—chronic kidney failure	0.000273	0.00777	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SCARB1—chronic kidney failure	0.000272	0.00775	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—PTGS1—chronic kidney failure	0.000269	0.00767	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP2C18—chronic kidney failure	0.000262	0.00746	CbGpPWpGaD
Nepafenac—Tiaprofenic acid—PTGS2—chronic kidney failure	0.00026	0.0252	CrCbGaD
Nepafenac—Carbamazepine—CYP2B6—chronic kidney failure	0.000258	0.025	CrCbGaD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—FASN—chronic kidney failure	0.000254	0.00723	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CAT—chronic kidney failure	0.000244	0.00696	CbGpPWpGaD
Nepafenac—Magnesium salicylate—PTGS2—chronic kidney failure	0.000242	0.0234	CrCbGaD
Nepafenac—PTGS1—Overview of nanoparticle effects—IL6—chronic kidney failure	0.000241	0.00688	CbGpPWpGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—CYP1A1—chronic kidney failure	0.000241	0.00686	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—TNF—chronic kidney failure	0.000237	0.00677	CbGpPWpGaD
Nepafenac—Mebendazole—CYP3A4—chronic kidney failure	0.000237	0.0229	CrCbGaD
Nepafenac—Fenbufen—PTGS2—chronic kidney failure	0.000236	0.0229	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ABCA1—chronic kidney failure	0.000229	0.00652	CbGpPWpGaD
Nepafenac—Oxcarbazepine—CYP2C19—chronic kidney failure	0.000229	0.0222	CrCbGaD
Nepafenac—Carbamazepine—ABCC2—chronic kidney failure	0.000224	0.0217	CrCbGaD
Nepafenac—PTGS1—renal system—chronic kidney failure	0.000221	0.0409	CbGeAlD
Nepafenac—PTGS1—cardiovascular system—chronic kidney failure	0.000219	0.0404	CbGeAlD
Nepafenac—PTGS1—Biological oxidations—CYP2C19—chronic kidney failure	0.000217	0.00618	CbGpPWpGaD
Nepafenac—Magnesium salicylate—ALB—chronic kidney failure	0.000215	0.0209	CrCbGaD
Nepafenac—PTGS1—kidney—chronic kidney failure	0.000214	0.0395	CbGeAlD
Nepafenac—PTGS2—renal system—chronic kidney failure	0.000211	0.0391	CbGeAlD
Nepafenac—PTGS2—cardiovascular system—chronic kidney failure	0.000209	0.0386	CbGeAlD
Nepafenac—PTGS2—urethra—chronic kidney failure	0.000208	0.0384	CbGeAlD
Nepafenac—Salsalate—PTGS2—chronic kidney failure	0.000205	0.0199	CrCbGaD
Nepafenac—PTGS2—kidney—chronic kidney failure	0.000204	0.0378	CbGeAlD
Nepafenac—PTGS1—Arachidonic acid metabolism—PTGS2—chronic kidney failure	0.000204	0.00582	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—MTHFR—chronic kidney failure	0.000204	0.00581	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.000202	0.00575	CbGpPWpGaD
Nepafenac—Diclofenac—PTGS1—chronic kidney failure	0.000198	0.0192	CrCbGaD
Nepafenac—Mebendazole—ABCB1—chronic kidney failure	0.000197	0.0191	CrCbGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CRP—chronic kidney failure	0.000194	0.00552	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CAT—chronic kidney failure	0.000194	0.00552	CbGpPWpGaD
Nepafenac—PTGS2—Overview of nanoparticle effects—IL6—chronic kidney failure	0.000191	0.00546	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—NOS1—chronic kidney failure	0.000186	0.0053	CbGpPWpGaD
Nepafenac—Diclofenac—CYP2C19—chronic kidney failure	0.000182	0.0176	CrCbGaD
Nepafenac—PTGS1—digestive system—chronic kidney failure	0.000181	0.0335	CbGeAlD
Nepafenac—Diclofenac—CYP1A1—chronic kidney failure	0.000181	0.0175	CrCbGaD
Nepafenac—PTGS1—Phase 1 - Functionalization of compounds—POMC—chronic kidney failure	0.000179	0.00511	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—F2—chronic kidney failure	0.000179	0.0051	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—RELA—chronic kidney failure	0.000178	0.00508	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ICAM1—chronic kidney failure	0.000178	0.00508	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS1—chronic kidney failure	0.000175	0.017	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000175	0.00499	CbGpPWpGaD
Nepafenac—PTGS2—digestive system—chronic kidney failure	0.000173	0.0321	CbGeAlD
Nepafenac—PTGS1—blood—chronic kidney failure	0.000173	0.032	CbGeAlD
Nepafenac—PTGS1—Biological oxidations—CYP3A4—chronic kidney failure	0.000172	0.00489	CbGpPWpGaD
Nepafenac—Modafinil—CYP2C19—chronic kidney failure	0.000171	0.0166	CrCbGaD
Nepafenac—Fenoprofen—PTGS2—chronic kidney failure	0.00017	0.0164	CrCbGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—chronic kidney failure	0.000168	0.00479	CbGpPWpGaD
Nepafenac—PTGS2—blood—chronic kidney failure	0.000165	0.0305	CbGeAlD
Nepafenac—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—chronic kidney failure	0.000163	0.00465	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—MTHFR—chronic kidney failure	0.000162	0.00461	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FABP1—chronic kidney failure	0.00016	0.00457	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—CCL2—chronic kidney failure	0.000159	0.00454	CbGpPWpGaD
Nepafenac—Mefenamic acid—PTGS2—chronic kidney failure	0.000157	0.0153	CrCbGaD
Nepafenac—Carbamazepine—CYP2C19—chronic kidney failure	0.000156	0.0151	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CRP—chronic kidney failure	0.000154	0.00438	CbGpPWpGaD
Nepafenac—Fenoprofen—ALB—chronic kidney failure	0.000151	0.0147	CrCbGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—chronic kidney failure	0.00015	0.00429	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—SERPINE1—chronic kidney failure	0.000149	0.00424	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—ALB—chronic kidney failure	0.000148	0.00423	CbGpPWpGaD
Nepafenac—Oxcarbazepine—CYP3A4—chronic kidney failure	0.000145	0.0141	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—F2—chronic kidney failure	0.000142	0.00405	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ICAM1—chronic kidney failure	0.000141	0.00403	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ACAT1—chronic kidney failure	0.000139	0.00396	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.000138	0.00394	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—chronic kidney failure	0.000136	0.00389	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000135	0.00386	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—RELA—chronic kidney failure	0.000134	0.00381	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.00013	0.00371	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—PTGS2—chronic kidney failure	0.00013	0.0037	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—CYP1A1—chronic kidney failure	0.000128	0.00364	CbGpPWpGaD
Nepafenac—Oxcarbazepine—ALB—chronic kidney failure	0.000127	0.0123	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—CCL2—chronic kidney failure	0.000127	0.00361	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL1B—chronic kidney failure	0.000121	0.00345	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—SERPINE1—chronic kidney failure	0.000118	0.00337	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—ALB—chronic kidney failure	0.000118	0.00336	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—TNF—chronic kidney failure	0.000117	0.00333	CbGpPWpGaD
Nepafenac—PTGS2—Aryl Hydrocarbon Receptor—KRAS—chronic kidney failure	0.000116	0.00331	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	0.000116	0.0033	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	0.000116	0.0033	CbGpPWpGaD
Nepafenac—Diclofenac—CYP3A4—chronic kidney failure	0.000116	0.0112	CrCbGaD
Nepafenac—Diclofenac—PTGS2—chronic kidney failure	0.000113	0.011	CrCbGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—NFKB1—chronic kidney failure	0.000113	0.00321	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—ICAM1—chronic kidney failure	0.000112	0.00319	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCG1—chronic kidney failure	0.00011	0.00313	CbGpPWpGaD
Nepafenac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic kidney failure	0.000109	0.00312	CbGpPWpGaD
Nepafenac—Modafinil—CYP3A4—chronic kidney failure	0.000109	0.0105	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	0.000109	0.00309	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PIP5K1B—chronic kidney failure	0.000107	0.00306	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—RELA—chronic kidney failure	0.000106	0.00303	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	0.000105	0.00299	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LCAT—chronic kidney failure	0.000103	0.00294	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	0.000103	0.00292	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—chronic kidney failure	0.000101	0.00289	CbGpPWpGaD
Nepafenac—Diclofenac—ALB—chronic kidney failure	0.000101	0.00977	CrCbGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	0.0001	0.00286	CbGpPWpGaD
Nepafenac—Ketoprofen—PTGS2—chronic kidney failure	0.0001	0.00971	CrCbGaD
Nepafenac—PTGS2—Spinal Cord Injury—CCL2—chronic kidney failure	0.0001	0.00285	CbGpPWpGaD
Nepafenac—Carbamazepine—CYP3A4—chronic kidney failure	9.91e-05	0.00961	CrCbGaD
Nepafenac—Diclofenac—ABCB1—chronic kidney failure	9.62e-05	0.00932	CrCbGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL1B—chronic kidney failure	9.59e-05	0.00274	CbGpPWpGaD
Nepafenac—PTGS1—Biological oxidations—POMC—chronic kidney failure	9.53e-05	0.00272	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PRKD1—chronic kidney failure	9.2e-05	0.00262	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PRKAG2—chronic kidney failure	9.2e-05	0.00262	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FABP1—chronic kidney failure	8.99e-05	0.00256	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—NFKB1—chronic kidney failure	8.95e-05	0.00255	CbGpPWpGaD
Nepafenac—Ketoprofen—ALB—chronic kidney failure	8.93e-05	0.00865	CrCbGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—TNF—chronic kidney failure	8.77e-05	0.0025	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—chronic kidney failure	8.61e-05	0.00246	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	8.54e-05	0.00244	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—AGXT—chronic kidney failure	8.52e-05	0.00243	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GATM—chronic kidney failure	8.52e-05	0.00243	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	8.33e-05	0.00237	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	8.33e-05	0.00237	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCC3—chronic kidney failure	8.32e-05	0.00237	CbGpPWpGaD
Nepafenac—Carbamazepine—ABCB1—chronic kidney failure	8.25e-05	0.008	CrCbGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPIN1—chronic kidney failure	8.14e-05	0.00232	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LRP2—chronic kidney failure	7.98e-05	0.00227	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ACAT1—chronic kidney failure	7.79e-05	0.00222	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	7.69e-05	0.00219	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL1B—chronic kidney failure	7.59e-05	0.00216	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	7.47e-05	0.00213	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	7.26e-05	0.00207	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MLXIPL—chronic kidney failure	7.24e-05	0.00206	CbGpPWpGaD
Nepafenac—PTGS2—C-MYB transcription factor network—KRAS—chronic kidney failure	7.17e-05	0.00204	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FABP1—chronic kidney failure	7.13e-05	0.00203	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	7.11e-05	0.00203	CbGpPWpGaD
Nepafenac—PTGS1—Selenium Micronutrient Network—IL6—chronic kidney failure	7.08e-05	0.00202	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—TNF—chronic kidney failure	6.96e-05	0.00198	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CPT1A—chronic kidney failure	6.78e-05	0.00193	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—AGXT—chronic kidney failure	6.76e-05	0.00193	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GATM—chronic kidney failure	6.76e-05	0.00193	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—chronic kidney failure	6.69e-05	0.00191	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SLC22A2—chronic kidney failure	6.62e-05	0.00189	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LIPC—chronic kidney failure	6.61e-05	0.00188	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP2C19—chronic kidney failure	6.61e-05	0.00188	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	6.47e-05	0.00185	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ACAT1—chronic kidney failure	6.19e-05	0.00176	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCG1—chronic kidney failure	6.16e-05	0.00176	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—chronic kidney failure	6.11e-05	0.00174	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—chronic kidney failure	6.05e-05	0.00172	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PIP5K1B—chronic kidney failure	6.03e-05	0.00172	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—SREBF1—chronic kidney failure	5.93e-05	0.00169	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ARG2—chronic kidney failure	5.9e-05	0.00168	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TGFB1—chronic kidney failure	5.9e-05	0.00168	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TFDP2—chronic kidney failure	5.84e-05	0.00166	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LCAT—chronic kidney failure	5.79e-05	0.00165	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—chronic kidney failure	5.77e-05	0.00164	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MLXIPL—chronic kidney failure	5.75e-05	0.00164	CbGpPWpGaD
Nepafenac—PTGS2—Disease—PIP5K1B—chronic kidney failure	5.71e-05	0.00163	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—FASN—chronic kidney failure	5.64e-05	0.00161	CbGpPWpGaD
Nepafenac—PTGS2—Selenium Micronutrient Network—IL6—chronic kidney failure	5.62e-05	0.0016	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—TNF—chronic kidney failure	5.51e-05	0.00157	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—DDC—chronic kidney failure	5.32e-05	0.00152	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SLC22A2—chronic kidney failure	5.26e-05	0.0015	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2B6—chronic kidney failure	5.16e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PRKAG2—chronic kidney failure	5.16e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PRKD1—chronic kidney failure	5.16e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—chronic kidney failure	5.14e-05	0.00147	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	5.08e-05	0.00145	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	4.91e-05	0.0014	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCG1—chronic kidney failure	4.89e-05	0.00139	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF2—chronic kidney failure	4.83e-05	0.00138	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—chronic kidney failure	4.81e-05	0.00137	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PIP5K1B—chronic kidney failure	4.78e-05	0.00136	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ARG2—chronic kidney failure	4.69e-05	0.00134	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—GCKR—chronic kidney failure	4.67e-05	0.00133	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCC3—chronic kidney failure	4.67e-05	0.00133	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LCAT—chronic kidney failure	4.6e-05	0.00131	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPIN1—chronic kidney failure	4.57e-05	0.0013	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	4.49e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2C18—chronic kidney failure	4.47e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LRP2—chronic kidney failure	4.47e-05	0.00128	CbGpPWpGaD
Nepafenac—PTGS2—Spinal Cord Injury—IL6—chronic kidney failure	4.44e-05	0.00127	CbGpPWpGaD
Nepafenac—PTGS2—Disease—GCKR—chronic kidney failure	4.42e-05	0.00126	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—chronic kidney failure	4.37e-05	0.00125	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LRP2—chronic kidney failure	4.24e-05	0.00121	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—DDC—chronic kidney failure	4.22e-05	0.0012	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PRKD1—chronic kidney failure	4.1e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2B6—chronic kidney failure	4.1e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PRKAG2—chronic kidney failure	4.1e-05	0.00117	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—LPL—chronic kidney failure	4.03e-05	0.00115	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—chronic kidney failure	4.01e-05	0.00114	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBB—chronic kidney failure	3.94e-05	0.00112	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—chronic kidney failure	3.9e-05	0.00111	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF2—chronic kidney failure	3.84e-05	0.00109	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CPT1A—chronic kidney failure	3.8e-05	0.00108	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—chronic kidney failure	3.75e-05	0.00107	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CST3—chronic kidney failure	3.73e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FGF23—chronic kidney failure	3.73e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—chronic kidney failure	3.72e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LIPC—chronic kidney failure	3.71e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP2C19—chronic kidney failure	3.71e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—GCKR—chronic kidney failure	3.71e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCC3—chronic kidney failure	3.71e-05	0.00106	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	3.66e-05	0.00104	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPIN1—chronic kidney failure	3.63e-05	0.00103	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—PPARA—chronic kidney failure	3.56e-05	0.00102	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LRP2—chronic kidney failure	3.55e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2C18—chronic kidney failure	3.55e-05	0.00101	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SCARB1—chronic kidney failure	3.43e-05	0.000977	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	3.34e-05	0.000951	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—SREBF1—chronic kidney failure	3.33e-05	0.000948	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NCF1—chronic kidney failure	3.25e-05	0.000926	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—HMGCR—chronic kidney failure	3.24e-05	0.000922	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—FASN—chronic kidney failure	3.17e-05	0.000903	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CYBA—chronic kidney failure	3.05e-05	0.00087	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CPT1A—chronic kidney failure	3.02e-05	0.000861	CbGpPWpGaD
Nepafenac—PTGS2—Disease—FASN—chronic kidney failure	3e-05	0.000856	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LIPC—chronic kidney failure	2.94e-05	0.000839	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP2C19—chronic kidney failure	2.94e-05	0.000839	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP3A4—chronic kidney failure	2.93e-05	0.000836	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—chronic kidney failure	2.92e-05	0.000832	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—POMC—chronic kidney failure	2.9e-05	0.000828	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCA1—chronic kidney failure	2.88e-05	0.000822	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS1—chronic kidney failure	2.81e-05	0.000801	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SCARB1—chronic kidney failure	2.72e-05	0.000775	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PTGS1—chronic kidney failure	2.69e-05	0.000768	CbGpPWpGaD
Nepafenac—PTGS2—Disease—HBEGF—chronic kidney failure	2.68e-05	0.000764	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism of lipids and lipoproteins—ALB—chronic kidney failure	2.65e-05	0.000755	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—SREBF1—chronic kidney failure	2.64e-05	0.000753	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—HMGCR—chronic kidney failure	2.57e-05	0.000732	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—FASN—chronic kidney failure	2.51e-05	0.000717	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CAT—chronic kidney failure	2.44e-05	0.000696	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ABCB1—chronic kidney failure	2.37e-05	0.000677	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP3A4—chronic kidney failure	2.33e-05	0.000664	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCA1—chronic kidney failure	2.29e-05	0.000653	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—LPL—chronic kidney failure	2.26e-05	0.000645	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—CYP1A1—chronic kidney failure	2.19e-05	0.000623	CbGpPWpGaD
Nepafenac—PTGS2—Disease—LPL—chronic kidney failure	2.14e-05	0.000611	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—MTHFR—chronic kidney failure	2.04e-05	0.000581	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PPARA—chronic kidney failure	2e-05	0.00057	CbGpPWpGaD
Nepafenac—PTGS2—Disease—CCR5—chronic kidney failure	1.98e-05	0.000563	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CAT—chronic kidney failure	1.94e-05	0.000552	CbGpPWpGaD
Nepafenac—PTGS2—Disease—MTHFR—chronic kidney failure	1.93e-05	0.000551	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ABCB1—chronic kidney failure	1.89e-05	0.000537	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—LPL—chronic kidney failure	1.8e-05	0.000512	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—CYP1A1—chronic kidney failure	1.73e-05	0.000495	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—POMC—chronic kidney failure	1.63e-05	0.000465	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—MTHFR—chronic kidney failure	1.62e-05	0.000461	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IRS1—chronic kidney failure	1.6e-05	0.000457	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—PPARA—chronic kidney failure	1.59e-05	0.000452	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—ALB—chronic kidney failure	1.49e-05	0.000424	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—NOS3—chronic kidney failure	1.42e-05	0.000405	CbGpPWpGaD
Nepafenac—PTGS2—Disease—SERPINE1—chronic kidney failure	1.41e-05	0.000402	CbGpPWpGaD
Nepafenac—PTGS2—Disease—NOS3—chronic kidney failure	1.35e-05	0.000384	CbGpPWpGaD
Nepafenac—PTGS1—Metabolism—PTGS2—chronic kidney failure	1.3e-05	0.000371	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—POMC—chronic kidney failure	1.29e-05	0.000369	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—ALB—chronic kidney failure	1.18e-05	0.000336	CbGpPWpGaD
Nepafenac—PTGS2—Metabolism—NOS3—chronic kidney failure	1.13e-05	0.000322	CbGpPWpGaD
Nepafenac—PTGS2—Disease—TGFB1—chronic kidney failure	8.91e-06	0.000254	CbGpPWpGaD
Nepafenac—PTGS2—Disease—KRAS—chronic kidney failure	8.25e-06	0.000235	CbGpPWpGaD
Nepafenac—PTGS2—Disease—IL6—chronic kidney failure	6.71e-06	0.000191	CbGpPWpGaD
